4SC AG (FRA:VSC) ROCE % : -75.79% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is 4SC AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. 4SC AG's annualized ROCE % for the quarter that ended in Dec. 2023 was -75.79%.

4SC AG ROCE % Historical Data

The historical data trend for 4SC AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4SC AG ROCE % Chart

4SC AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-35.29

-42.80

-27.61

-61.88

-76.66

4SC AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															-64.44	-90.35	-35.10	-65.96	-75.79

4SC AG ROCE % Calculation

4SC AG's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-8.119	/	( ( (16.401 - 0.933)	+	(9.403 - 3.69) )	/ 2 )
	=	-8.119	/	( (15.468	+	5.713)	/ 2 )
	=	-8.119	/	10.5905
	=	-76.66 %

4SC AG's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-6.962	/	( ( (13.365 - 0.707)	+	(9.403 - 3.69) )	/ 2 )
	=	-6.962	/	( ( 12.658	+	5.713 )	/ 2 )
	=	-6.962	/	9.1855
	=	-75.79 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

4SC AG (FRA:VSC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

4SC AG ROCE % Related Terms

Thank you for viewing the detailed overview of 4SC AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

4SC AG (FRA:VSC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4SC AG (FRA:VSC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

VSC:Germany

Address

Fraunhoferstraße 22, Planegg-Martinsried, DEU, 82152

Website

https://www.4sc.com

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. It Geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.

4SC AG (FRA:VSC) Headlines

No Headlines